Did Depo-Provera give you a brain tumor?
Women who used Depo-Provera for a year or more face a 5.6× higher risk of meningioma. If you have been diagnosed, you may be entitled to major compensation. Pfizer knew — and hid it from US patients for 9 years.
Have you ever received a Depo-Provera injection?
Includes branded Depo-Provera, Depo-SubQ Provera 104, or generic medroxyprogesterone acetate (MPA).
- No fees unless you win
- 100% free, confidential
- Trial attorneys on the PSC
- Available nationwide
A 9-year warning gap.
Health Canada warned about meningioma risk in 2015. France warned in 2019. The UK warned in 2023. But Pfizer didn't update the US label until Q4 2024 — and only after litigation began.
- Failure to warnPfizer concealed known meningioma risk from US doctors and patients for nearly a decade.
- Clear medical link~70% of meningiomas express progesterone receptors — the exact hormone in Depo-Provera.
- Active MDLConsolidated before Judge M. Casey Rodgers in Northern District of Florida.
What your claim could be worth
Based on injury severity tiers cited by lead plaintiff firms. Individual outcomes vary.
Asymptomatic meningioma under active monitoring.
Required craniotomy or radiosurgery to remove the tumor.
Multiple surgeries, neurological deficits, vision loss.
Settlement ranges are projections based on bellwether posture and European progestin-meningioma comparators. Past results do not guarantee future outcomes.
From form to filing in four steps
Answer 6 quick questions. Takes about 60 seconds. Completely confidential.
A senior case specialist calls you within 15 minutes during business hours.
If you qualify, we handle everything — medical record review, filing, and litigation.
No upfront costs. No hourly fees. We only get paid if you receive compensation.
Trusted by women across the country
"I had no idea Depo-Provera could cause a brain tumor. My case specialist walked me through everything in plain English."
"I was nervous to call. Within a week of my surgery, they had all my records and a claim filed. No paperwork on my end."
"They were honest with me about what to expect. No pressure, no scripts. Real people who genuinely cared."
Testimonials reflect individual experiences and are not a guarantee of outcome. Names and locations may be changed to protect client privacy.
Answers, not legal jargon
Who qualifies for a Depo-Provera lawsuit?+
Generally: women who received one or more Depo-Provera injections (branded, generic, or Depo-SubQ), were later diagnosed with a meningioma confirmed by imaging or pathology, and do not currently have other legal representation for this claim. Use of one year or more significantly strengthens a case.
How much does it cost to get my case reviewed?+
Nothing. The case review is 100% free and confidential. If we take your case, you owe nothing unless we win compensation for you. Standard contingency fee applies only on recovery.
How long do I have to file?+
Most states apply a 2-year statute of limitations with a discovery rule. The March 2024 BMJ publication is commonly treated as the discovery trigger, so most claimants have through at least early 2026 to file — but several states (FL, NJ, KY, LA, TN) have tighter rules. Don't wait to find out.
What about my medical records?+
Once you're a client, we handle all medical record retrieval at no cost to you. You don't need to gather anything before your call.
Will I have to go to court?+
The vast majority of mass tort claims resolve through settlement. If your case is selected as a bellwether or the defendant refuses to settle, your attorneys will prepare you and represent you at every step.
Is this a class action?+
No. It's a multidistrict litigation (MDL) — your case stays individual and is valued on your specific injuries. MDL No. 3140 is consolidated in the Northern District of Florida before Judge M. Casey Rodgers.
You only get one chance to file. Make it count.
The MDL is moving fast. Bellwether trials begin late 2026. Take 60 seconds to see if you qualify — there's no cost, no obligation, and no pressure.